Clinical Trial Update: A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on combining ciprofloxacin with gemcitabine and nab-paclitaxel for metastatic pancreatic cancer; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Gemzar (gemcitabine)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING